Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selenium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116574072A details a green visible-light method for 2,5-diaryl furans. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102942451A details a green method for 1,2-diol production using recyclable selenium polymers, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel selenium-mediated cyclization for 2-benzoxazepines. High yield, mild conditions. Ideal for CNS drug intermediates. Cost-effective manufacturing solution.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117088826B enables visible-light synthesis of polysubstituted oxazoles without transition metals, offering greener manufacturing and enhanced supply chain reliability for pharmaceutical intermediates.
Solve 6-substituted phenanthridine synthesis challenges with non-precious metal catalysis. 85% yield, mild conditions, and scalable production for pharma R&D and procurement.